{"title":"Signs of right ventricular myocyte hypertrophy in arrhythmogenic cardiomyopathy","authors":"S. Peters","doi":"10.15761/hpc.1000160","DOIUrl":null,"url":null,"abstract":"In human and mouse models mutations of desmoglein-2 produce a form of arrhythmogenic cardiomyopathy with massive necrosis and right ventricular myocyte hypertrophy. In a cohort of 434 patients with typical arrhythmogenic cardiomyopathy it was searched for signs of right ventricular hypertrophy in standard ECG. In 12 cases manifest or subtle signs of right ventricular hypertrophy were present (3%) beyond minor or major ECG criteria of arrhythmogenic cardiomyopathy. Although desmoglein-2 mutations have a frequency of 5 – 15% in arrhythmogenic cardiomyopathy additional signs of right ventricular hypertrophy are a hint of massive necrosis in arrhythmogenic cardiomyopathy thus producing right ventricular myocyte hypertrophy. *Correspondence to: Stefan Peters, Cardiology, St.Elisabeth Hospital Salzgitter, Liebenhaller Str. 20, 38259 Salzgitter, Germany, Tel: +39 5341 824 679; E-Mail: H.u.S.Peters@t-online.de","PeriodicalId":48703,"journal":{"name":"Primary Health Care Research and Development","volume":"29 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Health Care Research and Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15761/hpc.1000160","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 1
Abstract
In human and mouse models mutations of desmoglein-2 produce a form of arrhythmogenic cardiomyopathy with massive necrosis and right ventricular myocyte hypertrophy. In a cohort of 434 patients with typical arrhythmogenic cardiomyopathy it was searched for signs of right ventricular hypertrophy in standard ECG. In 12 cases manifest or subtle signs of right ventricular hypertrophy were present (3%) beyond minor or major ECG criteria of arrhythmogenic cardiomyopathy. Although desmoglein-2 mutations have a frequency of 5 – 15% in arrhythmogenic cardiomyopathy additional signs of right ventricular hypertrophy are a hint of massive necrosis in arrhythmogenic cardiomyopathy thus producing right ventricular myocyte hypertrophy. *Correspondence to: Stefan Peters, Cardiology, St.Elisabeth Hospital Salzgitter, Liebenhaller Str. 20, 38259 Salzgitter, Germany, Tel: +39 5341 824 679; E-Mail: H.u.S.Peters@t-online.de
期刊介绍:
Primary Health Care Research & Development is aimed specifically at both researchers and practitioners in primary health care, bridging the gap between the two areas. It provides a forum for the publication of international, interdisciplinary research and development in primary health care. It is essential reading for all involved in primary care: nurse practitioners, GPs and health service managers; professional and local groups in community health; researchers and academics; purchasers of primary health care services; allied health practitioners in secondary services and health-related consumer groups.